Single-dose pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 in healthy subjects
Author:
Affiliation:
1. Eli Lilly and Company; Indianapolis IN USA
2. Lilly-NUS Centre for Clinical Pharmacology; Singapore Singapore
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference26 articles.
1. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials;Bazzano;Diabet Med,2008
2. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients;Riddle;Diabetes Care,2003
3. DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes;Buse;Diabetes Care,2009
4. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes 2;Nathan;Diabetes Care,2009
5. Insulin therapy for type 2 diabetes;Swinnen;Diabetes Care,2009
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Insulin prodrugs with programmed chemical release of an intramolecular cross-link;2024-09-06
2. Predicting human half-life for insulin analogs: An inter-drug approach;European Journal of Pharmaceutics and Biopharmaceutics;2024-08
3. Current usage of long-acting insulin analogs in patients with type 2 diabetes mellitus;Expert Review of Endocrinology & Metabolism;2024-02-20
4. Predicting Human Half-Life for Insulin Analogs: An Inter-Drug Approach;2024
5. Pharmacokinetics, Pharmacodynamics and Bioequivalence of Test Insulin Glargine versus Reference Preparation (Lantus®) in Healthy Male Volunteers—by Euglycemic Clamp Technique;2023-07-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3